Zajac JD - Search Results

1

Grossmann M, Gianatti EJ, Zajac JD. Grossmann M, et al. Among authors: zajac jd. Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):247-56. doi: 10.1097/MED.0b013e32833919cf. Curr Opin Endocrinol Diabetes Obes. 2010. PMID: 20418720 Review.

2

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G. Grossmann M, et al. Among authors: zajac jd. J Clin Endocrinol Metab. 2008 May;93(5):1834-40. doi: 10.1210/jc.2007-2177. Epub 2008 Mar 4. J Clin Endocrinol Metab. 2008. PMID: 18319314

3

Low testosterone and anaemia in men with type 2 diabetes.

Grossmann M, Panagiotopolous S, Sharpe K, MacIsaac RJ, Clarke S, Zajac JD, Jerums G, Thomas MC. Grossmann M, et al. Among authors: zajac jd. Clin Endocrinol (Oxf). 2009 Apr;70(4):547-53. doi: 10.1111/j.1365-2265.2008.03357.x. Epub 2008 Aug 13. Clin Endocrinol (Oxf). 2009. PMID: 18702678

4

Familial hyperaldosteronism type 1 in pregnancy.

Hamilton E, O'Callaghan C, O'Brien RM, Stowasser M, Gordon R, Zajac J, Grossmann M. Hamilton E, et al. Intern Med J. 2009 Feb;39(2):135-6. doi: 10.1111/j.1445-5994.2008.01869.x. Intern Med J. 2009. PMID: 19356193 No abstract available.

5

Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.

Vu T, Wong R, Hamblin PS, Zajac J, Grossmann M. Vu T, et al. Hosp Pract (1995). 2009 Dec;37(1):128-36. doi: 10.3810/hp.2009.12.266. Hosp Pract (1995). 2009. PMID: 20877181

6

Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy.

Hamilton EJ, Ghasem-Zadeh A, Gianatti E, Lim-Joon D, Bolton D, Zebaze R, Seeman E, Zajac JD, Grossmann M. Hamilton EJ, et al. Among authors: zajac jd. J Clin Endocrinol Metab. 2010 Dec;95(12):E456-63. doi: 10.1210/jc.2010-0902. Epub 2010 Sep 29. J Clin Endocrinol Metab. 2010. PMID: 20881261

7

Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?

Grossmann M, Zajac JD. Grossmann M, et al. Among authors: zajac jd. Clin Endocrinol (Oxf). 2011 Mar;74(3):289-93. doi: 10.1111/j.1365-2265.2010.03939.x. Clin Endocrinol (Oxf). 2011. PMID: 21092052

8

Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy.

Hamilton EJ, Gianatti E, Strauss BJ, Wentworth J, Lim-Joon D, Bolton D, Zajac JD, Grossmann M. Hamilton EJ, et al. Among authors: zajac jd. Clin Endocrinol (Oxf). 2011 Mar;74(3):377-83. doi: 10.1111/j.1365-2265.2010.03942.x. Clin Endocrinol (Oxf). 2011. PMID: 21118287

9

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.

Grossmann M, Hamilton EJ, Gilfillan C, Bolton D, Joon DL, Zajac JD. Grossmann M, et al. Among authors: zajac jd. Med J Aust. 2011 Mar 21;194(6):301-6. doi: 10.5694/j.1326-5377.2011.tb02979.x. Med J Aust. 2011. PMID: 21426285 Review.

10

Management of side effects of androgen deprivation therapy.

Grossmann M, Zajac JD. Grossmann M, et al. Among authors: zajac jd. Endocrinol Metab Clin North Am. 2011 Sep;40(3):655-71, x. doi: 10.1016/j.ecl.2011.05.004. Endocrinol Metab Clin North Am. 2011. PMID: 21889727 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters